Discovery and Development of Novel Therapeutics Course 2022, 6th Edition

Oct 9-13, 2022 – REGISTER BY 26 AUGUST 2022!

Coordinators: Catarina Brito (Animal Cell Technology Unit, IBET/ITQB), Heinz Ruffner (Novartis), Hansjörg Hauser (HZI, Germany)

ESACT offers an introductory course to the discovery and development of novel therapeutics. The content is spanning from small molecular weight drugs to biologics, including cellular and gene therapeutic products The course is planned in an intensive 4-day schedule with the number of participants limited to 30 in order to facilitate the interaction among them and with the lecturers. Lecturers will stay for the entire course duration. A limited number of grants, covering the course fee (not travel cost), are provided by ESACT. Applicants to the grants should indicate it in the course application, together with a motivation statement. Priority will be given to young Ph.D. students from academia. The course will cover the following topics:

  • Overview: From disease to target
  • Characteristics and main approaches to the development of drug types: Small molecular weight compounds, protein biologics, gene therapeutics, cell therapeutics
  • Assay development: Biochemical assays, assay development using cells, organoids and animals
  • Discovery of new small molecular weight drugs
  • Preclinical development of cell and gene therapy products
  • Outlook: Next steps towards clinics

Confirmed lecturers: Elisabeth Anderson (Charles River Laboratories, UK), Catarina Brito (IBET, Portugal), Hansjörg Hauser (HZI, Germany), Carsten Pieck (Merck, Germany), Heinz Ruffner (Novartis, Switzerland), Nikunj Somia (University of Minnesota, USA).

download flyer with information about Discovery and Development of Novel Therapeutics Course®

Organizing Committee

Catarina Brito
Animal Cell Technology Unit, IBET/ITQB
Apartado 12
2780-901 Oeiras, Portugal
Tel.: +351 21 44 69 434
Email: anabrito@ibet.pt

Heinz Ruffner
Novartis
WSJ-Fabrikstrasse 22-4.025.1
CH-4056 Basel, Switzerland
Tel +41 79 863 5219
Email: heinz.ruffner@novartis.com

Hansjörg Hauser
Helmholtz Centre for Infection Research (HZI)
Inhoffenstrasse 7
38124 Braunschweig, Germany
Tel.: +49 531 6181 5000
Email: hha@helmholtz-hzi.de

Contact for registration

Birgit Marckhgott
Email: office@esact.org

Registration Form Discovery and Development of Novel Therapeutics Course 2022

Application is open until AUGUST 26 – apply now!

By filling out and submitting the contact form below, you are applying to join the course. The Selection of participants will be based solely on the strength of your motivation letter and your CV (in case of applying for a grant). It does not depend on the date of receipt of the application.